ORIC Pharmaceuticals, Inc. (ORIC)
NMS – Real Time Price. Currency in USD
13.93
+0.20 (1.46%)
Market open: Aug 12, 2026, 12:11 PM EDT
13.78
+0.05 (0.36%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
13.93
+0.20 (1.46%)
Market open: Aug 12, 2026, 12:11 PM EDT
13.78
+0.05 (0.36%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $37.5M significantly exceed its total debt $3.3M, ensuring strong financial flexibility
Total current assets $273.7M exceed Total current liabilities $20.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$32.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 13.19 | 6.05 | 10 | |
| Quick ratio | 13.19 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -966K | -1M | -1M | -1M | -1M |
| Operating Income | -87M | -111M | -143M | -143M | -156M |
| Net Income | -89M | -101M | -128M | -129M | -140M |
| EBITDA | -86M | -110M | -142M | -142M | -155M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -15.77 | 1.0 |
| Next quarter | N/A | -34.8 | 1.0 |
| Current year | N/A | -2.19 | 1.0 |
| Next year | N/A | -9.49 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -16 | -11.75 | 4.4 | 4.0 |
| Y/Y | 999 | -14.12 | 19.15 | -2.04 | 5.3 |
| 3y average | 999 | -13.72 | 13.06 | -14.39 | 5.0 |
| 5y average | 999 | -12.23 | 13.78 | -20.67 | 5.0 |
| Weighted average score | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |